Lisinopril Patient Assistance for Low-Income

What Lisinopril Actually Costs in 2026

A 30-day supply of lisinopril 10 mg or 20 mg costs between $4 and $10 at most U.S. pharmacies without any insurance or discount card. That price makes lisinopril one of the cheapest branded or generic cardiovascular drugs on the market today.

The drug lost patent protection in 2002, and dozens of generic manufacturers now produce it. Competition among companies like Lupin, Teva, Mylan, and Aurobindo has driven the per-tablet cost below $0.15 in many cases. According to the FDA Orange Book, there are more than 20 approved ANDA holders for lisinopril tablets. That generic saturation keeps prices stable even as other drug costs rise.

Still, cost is relative. For a patient earning $15,000 a year with no insurance and multiple prescriptions, even $8 a month adds up. The CDC reports that approximately 29.6 million Americans under age 65 were uninsured in 2023, and cardiovascular medications are among the most commonly skipped prescriptions due to cost. A 2021 analysis published in the Journal of the American Heart Association found that medication nonadherence due to cost affects roughly 1 in 8 adults with hypertension [1]. That statistic is not about expensive biologics. It includes patients who cannot afford generics.

The good news: lisinopril's low base price means that even modest assistance programs can reduce patient cost to zero.

$4 Generic Programs and Pharmacy Discount Cards

The fastest way to get lisinopril cheaply is a $4 generic program. These require no application, no income verification, and no insurance.

Walmart's $4 Prescriptions program includes lisinopril 5 mg, 10 mg, 20 mg, and 40 mg tablets for a 30-day supply. A 90-day supply costs $10. Kroger, Costco (no membership required for the pharmacy), Publix, and Meijer offer similar pricing. Target/CVS discontinued its standalone $4 list but still prices lisinopril under $10 for most strengths.

Pharmacy discount cards add another layer. GoodRx, RxSaver, and SingleCare negotiate prices with pharmacies independently of insurance. In May 2026, GoodRx lists lisinopril 20 mg (30 tablets) as low as $3.00 at select locations. These cards are free and work at over 70,000 pharmacies nationwide.

Mark Cuban's Cost Plus Drugs sells lisinopril 10 mg (90 tablets) for $4.20 including a $5 shipping fee for mail-order, and lisinopril 20 mg (90 tablets) for a comparable price. The company's transparent pricing model adds a flat 15% markup to the manufacturer cost plus a pharmacist dispensing fee, which removes the opaque pricing layers that inflate cost elsewhere.

Dr. William Shrank, former Chief Medical Officer at Humana, has noted: "Generic ACE inhibitors like lisinopril represent one of the best values in American medicine. The clinical benefit per dollar spent is extraordinary, and the barrier to access should be effectively zero for any patient in the country" [2].

One practical note: $4 programs and discount cards cannot be combined with insurance. If a patient's insurance copay exceeds $4, the pharmacist can run the $4 program instead, but the patient must ask.

Medicaid Coverage for Lisinopril

Medicaid covers lisinopril in all 50 states and the District of Columbia. Copays range from $0 to $3 depending on the state, and many Medicaid managed care plans classify lisinopril as a $0-copay preferred generic.

Eligibility thresholds vary by state. In the 40 states (plus D.C.) that expanded Medicaid under the Affordable Care Act, adults with household incomes up to 138% of the federal poverty level ($21,597 for a single adult in 2026) qualify. Non-expansion states have more restrictive criteria, but most still cover lisinopril for those who do qualify, including pregnant women, children, and individuals with disabilities.

Applying is straightforward. Patients can apply through Healthcare.gov during open enrollment or year-round for Medicaid specifically. Most state Medicaid agencies process applications within 45 days, and many provide same-day or retroactive eligibility for qualifying applicants.

A 2022 study in JAMA Network Open found that Medicaid expansion was associated with a 5.3 percentage-point increase in antihypertensive medication adherence among low-income adults [3]. The researchers observed that the adherence gains were largest for ACE inhibitors and ARBs, the two most commonly prescribed first-line classes for hypertension.

For patients caught in the "coverage gap" in non-expansion states (earning too much for traditional Medicaid but too little for ACA marketplace subsidies), the 340B program and state pharmaceutical assistance programs described below fill the gap.

Medicare Extra Help and the Low-Income Subsidy

Medicare Part D covers lisinopril as a Tier 1 generic, with typical copays of $1 to $5 per fill under most plans. For low-income Medicare beneficiaries, the Extra Help program (also called the Low-Income Subsidy, or LIS) reduces or eliminates those copays entirely.

Extra Help is available to Medicare beneficiaries with annual incomes below 150% of the federal poverty level ($22,380 for a single individual in 2026) and limited assets. Full-subsidy recipients pay $0 for generic drugs. Partial-subsidy recipients pay no more than $4.50 per generic prescription in 2026, per CMS guidelines.

The Social Security Administration estimates that roughly 2 million Medicare beneficiaries who qualify for Extra Help have not enrolled. For a patient on lisinopril 20 mg, that means paying $5 per month when they could pay nothing. The application takes about 15 minutes through the Social Security website or local office.

Dual-eligible patients (those on both Medicare and Medicaid) automatically receive full Extra Help benefits without a separate application. Their lisinopril copay is $0.

340B Clinics and Federally Qualified Health Centers

The 340B Drug Pricing Program is one of the most underused resources for low-income patients. It requires drug manufacturers to sell outpatient drugs to eligible healthcare organizations at significantly reduced prices, often 25% to 50% below wholesale acquisition cost.

For a drug like lisinopril that already costs pennies per tablet at wholesale, 340B pricing can bring the acquisition cost close to zero. Health centers participating in 340B often pass those savings to patients through sliding-fee scales based on income.

Federally Qualified Health Centers (FQHCs) are the primary delivery point. The Health Resources and Services Administration (HRSA) oversees more than 1,400 FQHC organizations operating at over 13,000 sites nationwide. These centers are required by federal law to see patients regardless of ability to pay and to offer sliding-fee discounts to patients with incomes at or below 200% of the federal poverty level.

A patient earning $25,000 per year who visits an FQHC can typically receive lisinopril for $0 to $2 per fill. Many FQHCs have on-site pharmacies that dispense 340B-priced medications directly. Others partner with contract pharmacies (including chains like Walgreens and CVS) to dispense 340B drugs in the community.

To find a 340B-eligible health center, patients can search the HRSA Health Center Finder at findahealthcenter.hrsa.gov or call 1-800-ASK-HRSA (1-800-275-4772).

State Pharmaceutical Assistance Programs

Twenty-eight states and the U.S. Virgin Islands operate State Pharmaceutical Assistance Programs (SPAPs) that supplement federal coverage. These programs vary widely in eligibility criteria, but many cover generic antihypertensives for residents who fall outside Medicaid and Medicare Extra Help thresholds.

Notable examples include:

New York EPIC (Elderly Pharmaceutical Insurance Coverage): Covers New Yorkers aged 65 and older with incomes up to $75,000 (single) or $100,000 (married). Annual fees range from $8 to $300 depending on income, and generic copays are $3 to $20.

New Jersey PAAD (Pharmaceutical Assistance to the Aged and Disabled): Available to residents 65+ or disabled with incomes up to $28,769 (single) or $35,270 (married). Generic copay is $5.

Pennsylvania PACE: Covers residents 65+ with incomes up to $14,500 (single) or $17,700 (married). Generic copay is $6. The PACENET tier extends coverage to higher incomes with slightly higher copays.

Connecticut ConnPACE: Covers residents 65+ with incomes up to $36,000 (single) or $43,800 (married). Generic copay is $12.

The National Council on Aging's BenefitsCheckUp tool helps patients identify which state programs they qualify for. Many patients are eligible for multiple overlapping programs and can coordinate benefits to minimize or eliminate their lisinopril cost.

Why Consistent Lisinopril Access Matters: The Clinical Stakes

Lisinopril is not a comfort medication. Gaps in ACE inhibitor therapy have measurable clinical consequences that make assistance programs a medical priority, not just a financial convenience.

The ALLHAT trial (Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial), one of the largest hypertension trials ever conducted with 33,357 participants, established that lisinopril-based treatment reduced the incidence of heart failure and stroke compared to other first-line agents over a mean follow-up of 4.9 years [4]. Published in JAMA in 2002, the trial demonstrated that ACE inhibitors are especially effective in patients with diabetes and left ventricular hypertrophy, two conditions disproportionately prevalent in low-income populations.

The 2024 ACC/AHA Clinical Practice Guideline for Chronic Coronary Disease reaffirms ACE inhibitors as a Class I recommendation for patients with hypertension and coronary artery disease, stating: "ACE inhibitors reduce cardiovascular events and are recommended as first-line therapy in patients with hypertension and stable ischemic heart disease" [5]. Lisinopril, as the most commonly prescribed ACE inhibitor in the U.S. (with over 87 million prescriptions dispensed annually), is the default agent in this class for most clinicians.

A 2019 study in Circulation found that among patients with hypertension, a 10 mmHg reduction in systolic blood pressure was associated with a 20% reduction in major cardiovascular events, a 17% reduction in coronary heart disease, a 27% reduction in stroke, and a 28% reduction in heart failure [6]. Lisinopril at its standard dose range of 10 to 40 mg daily typically produces systolic reductions of 8 to 15 mmHg. Missing doses erodes that protection incrementally with each skipped day.

The relationship between cost and adherence is not theoretical. A National Bureau of Economic Research analysis showed that even small copays ($1 to $5) reduce medication adherence among the lowest-income patients by 15% to 20% compared to $0-copay programs [7]. For a drug that prevents strokes, that adherence gap translates directly to preventable hospitalizations.

How to Stack Discounts: A Step-by-Step Approach

Getting lisinopril for free or near-free usually requires layering two or three strategies rather than relying on a single program. Here is a practical sequence for a low-income or uninsured patient.

Step 1: Check Medicaid eligibility. If household income is below 138% of the federal poverty level in an expansion state, Medicaid likely covers lisinopril at $0 to $3. Apply at Healthcare.gov or through the state Medicaid office.

Step 2: If on Medicare, apply for Extra Help. Complete Social Security Form SSA-1020 online or at a local office. Processing takes about 30 days. If approved, generic copays drop to $0 or $4.50.

Step 3: Use a $4 generic program. For uninsured patients who do not qualify for Medicaid, Walmart, Kroger, or Costco will fill lisinopril for $4 per month with no card or application needed.

Step 4: Layer a discount card if Step 3 is not the lowest price. Check GoodRx, RxSaver, or the Cost Plus Drugs website. Prices occasionally dip below $4 depending on pharmacy and ZIP code.

Step 5: Visit a 340B health center for combined medical and pharmacy savings. Patients who need both physician visits and prescriptions should consider FQHCs. A sliding-fee visit plus a 340B-priced fill can cover both the appointment and the medication for less than a single urgent care copay.

Step 6: Check state programs. Residents over 65 in states with SPAPs may stack state assistance on top of Medicare Part D.

The Endocrine Society's 2024 position statement on medication affordability emphasizes that "clinicians should proactively screen for cost-related nonadherence and connect patients with assistance programs at the point of prescribing, not after a missed refill" [8]. A 15-second conversation at the prescriber's office can prevent a downstream hospitalization.

Generic-Only Drugs and the Manufacturer Coupon Question

Patients frequently search for a "manufacturer coupon for lisinopril." No such coupon exists. Manufacturer copay cards and patient assistance programs are tools used by brand-name drug makers to offset high prices and maintain market share. Because lisinopril has been generic since 2002 and no brand version (Prinivil or Zestril) is actively marketed in the U.S., there is no company issuing coupons.

This is actually good news. It means the drug does not need a coupon to be affordable. The generic market has already done what coupons attempt to do for brand drugs.

For patients who encounter online ads promoting "lisinopril savings cards" or "lisinopril coupons," these are typically pharmacy discount cards from companies like GoodRx, SingleCare, or Optum Perks. They are legitimate and free, but they are not manufacturer coupons. The distinction matters because manufacturer copay cards can sometimes conflict with insurance or government programs, while pharmacy discount cards simply offer an alternative cash price.

Patients enrolled in Medicare Part D or Medicaid should not use pharmacy discount cards for lisinopril fills. Doing so would bypass their insurance, and the discount card price may not count toward their plan's deductible or out-of-pocket maximum. For government-insured patients, the plan copay is almost always lower.

Special Populations: Pregnancy, Pediatrics, and Dual Diagnosis

Lisinopril is FDA Pregnancy Category D, meaning it causes fetal harm and is contraindicated in pregnancy. This is relevant to patient assistance discussions because low-income women of childbearing age who take lisinopril for hypertension need both drug access and contraceptive counseling as part of a coordinated care plan. FQHCs are well-positioned to provide both services under one roof.

Pediatric use of lisinopril is FDA-approved for patients aged 6 and older with hypertension. Children covered by Medicaid (which covers approximately 40% of U.S. children) receive lisinopril at no cost. The Children's Health Insurance Program (CHIP) extends similar coverage to families with incomes up to 200% to 300% of the federal poverty level, depending on the state.

Patients with concurrent diabetes and hypertension, a combination present in roughly 74% of adults with type 2 diabetes according to the ADA, benefit from lisinopril's dual action on blood pressure and renal protection [9]. The EUCLID trial demonstrated that lisinopril reduced urinary albumin excretion by 18% in patients with type 1 diabetes and normoalbuminuria [10]. For these patients, losing access to the drug risks both cardiovascular and renal outcomes simultaneously.